Cherenko, M, Appelman-Dijkstra, NM, Zurita, ALP, Biermasz, NR, Dekkers, OM, Klok, FA, Reisch, N, Aulinas, A, Biagetti, B, Cannavo, S, Canu, L, Detomas, M, Devuyst, F, Falhammar, H, Feelders, RA, Ferrau, F, Gatto, F, Grasselli, C, van Houten, P, Hoybye, C, Isidori, AM, Kyrilli, A, Loli, P, Maiter, D, Nowak, E, Pivonello, R, Ragnarsson, O, Steenaard, R, Unger, N, van de Ven, A, Webb, SM, Yeste, D, Ahmed, SF, Pereira, AM. Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey. Endocrine Connections. 2024; 13(6)DOI:10.1530/EC-24-0046. PMID:38614126. IF:2.800(Q3/6D).

O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Ribeiro-Oliveira, A Jr, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly (vol 40, pg 671, 2023). ADVANCES IN THERAPY. 2024; 41(6)DOI:10.1007/s12325-024-02829-6. PMID:38480663. IF:4.000(Q1/3D).

Bryk-Wiazania, AH, Minasyan, M, Swiatkowska-Stodulska, R, Undas, A, Hubalewska-Dydejczyk, A, Webb, SM, Valassi, E, Gilis-Januszewska, A. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1350010. PMID:38529392. IF:4.600(Q1/3D).

Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Corrales, EP, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Percovich, JC, Centeno, RG, González, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenéz, C, Galiana, PA, Moreno, EV, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, de Miguel, P, Mezquita, EL, Hanzu, F, Aldecoa, I, Lamas, C, Aznar, S, Aulinas, A, Calabrese, A, Gracia, P, Recio-Córdova, JM, Aviles, M, Asensio-Wandosel, D, Sampedro, M, Ruz-Caracuel, I, Camara, R, Paja, M, Fajardo-Montañana, C, Marazuela, M, Puig-Domingo, M. Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2024; 109(12)DOI:10.1210/clinem/dgae126. PMID:38436926. IF:5.100(Q1/2D).

Marques-Pamies, M, Gil, J, Valassi, E, Pons, L, Carrato, C, Jordà, M, Puig-Domingo, M. New molecular tools for precision medicine in pituitary neuroendocrine tumors. Minerva Endocrinology. 2024; 49(3)DOI:10.23736/S2724-6507.23.04063-0. PMID:38261299. IF:1.900(Q3/8D).

Marques-Pamies, M, Gil, J, Jordà, M, Puig-Domingo, M. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly. ARCHIVES OF MEDICAL RESEARCH. 2023; 54(8)DOI:10.1016/j.arcmed.2023.102924. PMID:38042683. IF:4.700(Q1/3D).